{
    "code": "02024570",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024570",
    "time": "2019-01-18 03:14:53",
    "許可證字號": "衛署藥輸字第024570號",
    "註銷狀態": "已註銷",
    "註銷日期": "107\/12\/21",
    "註銷理由": "自請註銷",
    "有效日期": "110\/11\/29",
    "發證日期": "95\/11\/29",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202457001",
    "中文品名": "克腎石持續性藥效錠",
    "英文品名": "Urocit-K 10meq Tablet",
    "適應症": "鈣石症引起之腎小管酸中毒，任何病理所引起的低檸檬酸尿草酸鈣腎石症和尿酸結石(有或無鈣結石)。",
    "劑型": "121持續性藥效錠",
    "包裝": "2-1000錠塑膠瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "POTASSIUMCITRATE"
    ],
    "限制項目": "02輸　入 1Q不得輸入",
    "申請商名稱": "620102D641  鴻佳實業有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F460383000  MISSION PHARMACAL COMPANY",
        "製造廠廠址": "38505 IH 10 WEST, BOERNE, TEXAS. 78006, U.S.A.",
        "製造廠公司地址": "10999 IH 10 WEST, SUITE 1000, SAN ANTONIO, TEXAS 78230, U.S.A."
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4008000300",
            "成分名稱": "POTASSIUM CITRATE",
            "含量描述": "",
            "含量": "1080.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "02024570仿單-104-12-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024570&Seq=003&Type=9"
        },
        {
            "title": "Urocit-K_瓶裝尺規圖檔-104-12-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024570&Seq=004&Type=8"
        }
    ]
}